captivatepharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * | ||
Meta Tags
| Title | vaccine adjuvant, CaPtivate Pharmaceuticals LLC |
| Description | CaPtivate Pharma is a development-stage biotechnology company developing novel or improved vaccines through its calcium phosphate (CaP) nanoparticle |
| Keywords | vaccine adjuvant,nanoparticles |
Server Information
| WebSite | |
| Host IP | 206.188.192.157 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
captivatepharma.com Valuation
|
US$630,898
Last updated: 2023-05-15 11:31:53
captivatepharma.com has Semrush global rank of 16,776,586. captivatepharma.com has an estimated worth of US$ 630,898, based on its estimated Ads revenue. captivatepharma.com receives approximately 72,796 unique visitors each day. Its web server is located in United States, with IP address 206.188.192.157. According to SiteAdvisor, captivatepharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$630,898 |
| Daily Ads Revenue | US$583 |
| Monthly Ads Revenue | US$17,472 |
| Yearly Ads Revenue | US$209,653 |
| Daily Unique Visitors | 4,854 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| captivatepharma.com. | A | 7200 | IP: 206.188.192.157 |
| captivatepharma.com. | NS | 7200 | NS Record: ns51.worldnic.com. |
| captivatepharma.com. | NS | 7200 | NS Record: ns52.worldnic.com. |
| captivatepharma.com. | MX | 7200 | MX Record: 10 mx002.netsol.xion.oxcs.net. |
| captivatepharma.com. | MX | 7200 | MX Record: 10 mx001.netsol.xion.oxcs.net. |
HtmlToTextCheckTime:2023-05-15 11:31:53
| ADVANCING VACCINES ENABLING DELIVERY Home About Us Facility Management & Advisors News Technology Vaccine Adjuvants CaP Nanoparticle Adjuvant Advantages of CaP Adjuvant Product Development Nasal Influenza Vaccines Pandemic Influenza Vaccines Partnering with CaPtivate Contact Us Home About Us Facility Management & Advisors News Technology Vaccine Adjuvants CaP Nanoparticle Adjuvant Advantages of CaP Adjuvant Product Development Nasal Influenza Vaccines Pandemic Influenza Vaccines Partnering with CaPtivate Contact Us Loading CaPtivatϵ Pharmaceuticals LLC is a privately-owned small biotechnology company focused on developing its proprietary calcium phosphate nanoparticle vaccine adjuvant and antigen delivery platform, CaP tivant TM (formarly called "BioVant") for applications in human or veterinary vaccines. The technology enables formulation of vaccines for parenteral or mucosal administration and for prophylactic or therapeutic use. While continuing to develop our own vaccine programs |
HTTP Headers
HTTP/1.1 200 OK Server: openresty/1.19.9.1 Date: Thu, 30 Dec 2021 09:56:36 GMT Content-Type: text/html Content-Length: 16765 Connection: keep-alive Vary: Accept-Encoding Last-Modified: Sun, 18 Apr 2021 18:07:20 GMT ETag: "417d-5c043158762f4" X-Webcom-Cache-Status: BYPASS Accept-Ranges: bytes |
captivatepharma.com Whois Information
Domain Name: CAPTIVATEPHARMA.COM Registry Domain ID: 1646672827_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2021-01-20T09:02:17Z Creation Date: 2011-03-21T22:15:04Z Registry Expiry Date: 2022-03-21T22:15:04Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS51.WORLDNIC.COM Name Server: NS52.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-30T07:48:52Z <<< |